Ivan Peyron/ISTH
Sep 15, 2025, 17:40
Ivan Peyron Encourages You to Support Resaerch Targeting Rare Coagulation Diseases and Platelet Pathologies
Ivan Peyron, Research Engineer at INSERM, shared on LinkedIn:
Support research!
Bleeding disorders and clotting problems are responsible for many serious illnesses and strokes.
Our mission in the laboratory:
- Deciphering the mechanisms of coagulation
- Understanding diseases like von Willebrand disease and hemophilia
- Improving diagnosis and treatment for patients
Thanks to our innovative nanobody platform (mini-antibodies) developed since 2014, we create:
- Unique tools for research
- Promising therapeutic candidates
Our current projects target rare coagulation diseases and platelet pathologies, to transform patients’ lives.
- By making a donation, you are directly contributing to:
- Better Stroke Prevention
- Improving the management of cardiovascular and inflammatory diseases
- Bringing hope to thousands of patients around the world
Support our research and help us make a difference!”
To support the research, follow the link.
Stay updated on the latest news in the field of clotting disorders with Hemostasis Today.
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH